342 related articles for article (PubMed ID: 34071976)
1. Therapies Targeted at Non-Coding RNAs in Prevention and Limitation of Myocardial Infarction and Subsequent Cardiac Remodeling-Current Experience and Perspectives.
Kowara M; Borodzicz-Jazdzyk S; Rybak K; Kubik M; Cudnoch-Jedrzejewska A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071976
[TBL] [Abstract][Full Text] [Related]
2. Role of long noncoding RNAs in pathological cardiac remodeling after myocardial infarction: An emerging insight into molecular mechanisms and therapeutic potential.
Yaghoobi A; Rezaee M; Behnoush AH; Khalaji A; Mafi A; Houjaghan AK; Masoudkabir F; Pahlavan S
Biomed Pharmacother; 2024 Mar; 172():116248. PubMed ID: 38325262
[TBL] [Abstract][Full Text] [Related]
3. Regulatory non-coding RNAs in acute myocardial infarction.
Guo Y; Luo F; Liu Q; Xu D
J Cell Mol Med; 2017 May; 21(5):1013-1023. PubMed ID: 27878945
[TBL] [Abstract][Full Text] [Related]
4. Promising roles of non-exosomal and exosomal non-coding RNAs in the regulatory mechanism and as diagnostic biomarkers in myocardial infarction.
Li J; Ma H; Wu X; Sun G; Yang P; Peng Y; Wang Q; Wang L
J Zhejiang Univ Sci B; 2023 Apr; 24(4):281-300. PubMed ID: 37056205
[TBL] [Abstract][Full Text] [Related]
5. Non-coding RNAs: The key detectors and regulators in cardiovascular disease.
Zhu L; Li N; Sun L; Zheng D; Shao G
Genomics; 2021 Jan; 113(1 Pt 2):1233-1246. PubMed ID: 33164830
[TBL] [Abstract][Full Text] [Related]
6. The pluripotent role of exosomes in mediating non-coding RNA in ventricular remodeling after myocardial infarction.
Qi Z; Wu D; Li M; Yan Z; Yang X; Ji N; Wang Y; Zhang J
Life Sci; 2020 Aug; 254():117761. PubMed ID: 32413403
[TBL] [Abstract][Full Text] [Related]
7. Targeting non-coding RNAs in unstable atherosclerotic plaques: Mechanism, regulation, possibilities, and limitations.
Li X; Yang Y; Wang Z; Jiang S; Meng Y; Song X; Zhao L; Zou L; Li M; Yu T
Int J Biol Sci; 2021; 17(13):3413-3427. PubMed ID: 34512156
[TBL] [Abstract][Full Text] [Related]
8. Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.
Nielsen SH; Mouton AJ; DeLeon-Pennell KY; Genovese F; Karsdal M; Lindsey ML
Matrix Biol; 2019 Jan; 75-76():43-57. PubMed ID: 29247693
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury.
Ong SB; Katwadi K; Kwek XY; Ismail NI; Chinda K; Ong SG; Hausenloy DJ
Expert Opin Ther Targets; 2018 Mar; 22(3):247-261. PubMed ID: 29417868
[TBL] [Abstract][Full Text] [Related]
10. The relevance of microRNA in post-infarction left ventricular remodelling and heart failure.
Dutka M; Bobiński R; Korbecki J
Heart Fail Rev; 2019 Jul; 24(4):575-586. PubMed ID: 30710255
[TBL] [Abstract][Full Text] [Related]
11. Non-coding RNAs modulate pyroptosis in myocardial ischemia-reperfusion injury: A comprehensive review.
Sun Y; Chu S; Wang R; Xia R; Sun M; Gao Z; Xia Z; Zhang Y; Dong S; Wang T
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128558. PubMed ID: 38048927
[TBL] [Abstract][Full Text] [Related]
12. PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis.
Wang Y; Ju C; Hu J; Huang K; Yang L
Biochem Biophys Res Commun; 2019 Dec; 520(3):645-650. PubMed ID: 31627895
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs: key players in cardiac disease.
Kreutzer FP; Fiedler J; Thum T
J Physiol; 2020 Jul; 598(14):2995-3003. PubMed ID: 31291008
[TBL] [Abstract][Full Text] [Related]
14. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.
Kowara M; Cudnoch-Jedrzejewska A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919446
[TBL] [Abstract][Full Text] [Related]
15. Transgenic overexpression of GTP cyclohydrolase 1 in cardiomyocytes ameliorates post-infarction cardiac remodeling.
Liu Y; Baumgardt SL; Fang J; Shi Y; Qiao S; Bosnjak ZJ; Vásquez-Vivar J; Xia Z; Warltier DC; Kersten JR; Ge ZD
Sci Rep; 2017 Jun; 7(1):3093. PubMed ID: 28596578
[TBL] [Abstract][Full Text] [Related]
16. Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction.
Kuhn TC; Knobel J; Burkert-Rettenmaier S; Li X; Meyer IS; Jungmann A; Sicklinger F; Backs J; Lasitschka F; Müller OJ; Katus HA; Krijgsveld J; Leuschner F
Circulation; 2020 May; 141(20):1628-1644. PubMed ID: 32100557
[TBL] [Abstract][Full Text] [Related]
17. Necroptosis mediated by impaired autophagy flux contributes to adverse ventricular remodeling after myocardial infarction.
Zhang H; Yin Y; Liu Y; Zou G; Huang H; Qian P; Zhang G; Zhang J
Biochem Pharmacol; 2020 May; 175():113915. PubMed ID: 32179044
[TBL] [Abstract][Full Text] [Related]
18. LncRNA
Liang H; Su X; Wu Q; Shan H; Lv L; Yu T; Zhao X; Sun J; Yang R; Zhang L; Yan H; Zhou Y; Li X; Du Z; Shan H
Autophagy; 2020 Jun; 16(6):1077-1091. PubMed ID: 31512556
[TBL] [Abstract][Full Text] [Related]
19. Role of noncoding RNAs in regulation of cardiac cell death and cardiovascular diseases.
Dong Y; Liu C; Zhao Y; Ponnusamy M; Li P; Wang K
Cell Mol Life Sci; 2018 Jan; 75(2):291-300. PubMed ID: 28913665
[TBL] [Abstract][Full Text] [Related]
20. A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.
Schirone L; Forte M; Palmerio S; Yee D; Nocella C; Angelini F; Pagano F; Schiavon S; Bordin A; Carrizzo A; Vecchione C; Valenti V; Chimenti I; De Falco E; Sciarretta S; Frati G
Oxid Med Cell Longev; 2017; 2017():3920195. PubMed ID: 28751931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
